IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Inc. (Nasdaq: SBC) has announced the approval of a share repurchase program, with the board authorizing a maximum aggregate amount of US $5 million. The repurchase is set to commence on May 20, 2025, and will continue until May 20, 2026, utilizing surplus cash and future free cash flow. The company aims to enhance shareholder value and address what it perceives as an undervaluation of its shares in the market.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SBC Medical Group Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9451247-en) on May 15, 2025, and is solely responsible for the information contained therein.